ONLINE DATABASE SEARCH -
OI-LS-374-MEMO
1.
60837 OI-LS-374;
PUBMED-OI-5/14/2007
Host Genetics of Mycobacterial Diseases in Mice and Men: Forward Genetic
Studies of BCG-osis and Tuberculosis
Fortin, A, Abel, L, Casanova, JL, and Gros, P
Annu Rev Genomics Hum Genet 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
60838 OI-LS-374;
PUBMED-OI-5/14/2007
Inhibition of Isolated Mycobacterium tuberculosis Fatty Acid Synthase I
by Pyrazinamide Analogs
Ngo, SC, Zimhony, O, Chung, WJ, Sayahi, H, Jacobs, WR Jr, and Welch,
JT
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
60839 OI-LS-374;
PUBMED-OI-5/14/2007
Determination of ethambutol MICs for Mycobacterium tuberculosis and
Mycobacterium avium isolates by resazurin microtitre assay
Jadaun, GP, Agarwal, C, Sharma, H, Ahmed, Z, Upadhyay, P, Faujdar, J,
Gupta, AK, Das, R, Gupta, P, Chauhan, DS, Sharma, VD, and Katoch,
VM
J Antimicrob Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
4.
60840 OI-LS-374;
PUBMED-OI-5/14/2007
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping
groups on inhibitory potency and pharmacokinetics
Perni, RB, Chandorkar, G, Cottrell, KM, Gates, CA, Lin, C, Lin, K, Luong,
YP, Maxwell, JP, Murcko, MA, Pitlik, J, Rao, G, Schairer, WC, Drie, JV, and Wei,
Y
Bioorg Med Chem Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
60841 OI-LS-374;
PUBMED-OI-5/14/2007
Synthesis and antifungal activities of new fluconazole analogues with
azaheterocycle moiety
Lebouvier, N, Pagniez, F, Duflos, M, Le, Pape P, Na, YM, Le, Baut G, and
Le, Borgne M
Bioorg Med Chem Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
6.
60842 OI-LS-374;
PUBMED-OI-5/14/2007
Structure, function and drug targeting in Mycobacterium tuberculosis
cytochrome P450 systems
McLean, KJ, Dunford, AJ, Neeli, R, Driscoll, MD, and Munro,
AW
Arch Biochem Biophys 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
7.
60843 OI-LS-374;
PUBMED-OI-5/14/2007
Inosine monophosphate dehydrogenase (IMPDH) as a target in drug
discovery
Shu, Q and Nair, V
Med Res Rev 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
60844 OI-LS-374;
PUBMED-OI-5/14/2007
Carbonic anhydrases as targets for medicinal chemistry
Supuran, CT and Scozzafava, A
Bioorg Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
60845 OI-LS-374;
PUBMED-OI-5/14/2007
Treatment of hepatitis C virus infection
Weigand, K, Stremmel, W, and Encke, J
World J Gastroenterol 2007.
13(13): 1897-905
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
60846 OI-LS-374;
PUBMED-OI-5/14/2007
Biochemical Mechanism of Hepatitis C Virus Inhibition by the
Broad-Spectrum Antiviral Arbidol
Pecheur, EI, Lavillette, D, Alcaras, F, Molle, J, Boriskin, YS, Roberts,
M, Cosset, FL, and Polyak, SJ
Biochemistry 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
60847 OI-LS-374;
PUBMED-OI-5/14/2007
XDR-TB--danger ahead
Singh, MM
Indian J Tuberc 2007.
54(1): 1-2
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
60848 OI-LS-374;
EMBASE-OI-5/14/2007
Entry of hepatitis C virus and human immunodeficiency virus is
selectively inhibited by carbohydrate-binding agents but not by
polyanions
Bertaux, Claire, Daelemans, Dirk, Meertens, Laurent, Cormier, Emmanuel G,
Reinus, John F, Peumans, Willy J, Van Damme, Els JM, Igarashi, Yasuhiro, Oki,
Toshikazu, Schols, Dominique, Dragic, Tatjana, and Balzarini,
Jan
Virology 2007. In
Press, Corrected Proof: 2064
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4NPHMH0-4/2/d0018d1e2ac221673bebf716f0d2d288
13.
60849 OI-LS-374;
PUBMED-OI-5/14/2007
Lumazine synthase from Candida albicans as an anti-fungal target enzyme:
Structural and biochemical basis for drug design
Morgunova, E, Saller, S, Haase, I, Cushman, M, Bacher, A, Fischer, M, and
Ladenstein, R
J Biol Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
60850 OI-LS-374;
PUBMED-OI-5/14/2007
Aptamer from whole-bacterium SELEX as new therapeutic reagent against
virulent Mycobacterium tuberculosis
Chen, F, Zhou, J, Luo, F, Mohammed, AB, and Zhang,
XL
Biochem Biophys Res Commun 2007. 357(3): 743-8
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
60851 OI-LS-374;
PUBMED-OI-5/14/2007
Tuberculosis: still a concern for all countries in Europe
Falzon, D and Belghiti, F
Euro Surveill 2007.
12(3): E070322.1
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
60852 OI-LS-374;
EMBASE-OI-5/14/2007
Inhibition of T-Cell Inflammatory Cytokines, Hepatocyte NF-[kappa]B
Signaling, and HCV Infection by Standardized Silymarin
Polyak, Stephen J, Morishima, Chihiro, Shuhart, Margaret C, Wang, Chia C,
Liu, Yanze, and Lee, David Y-W
Gastroenterology 2007.
132(5): 1925-1936
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WFX-4N3P02C-3/2/a1de6f3eeb52d0eb78d285656ee51cd6
17.
60853 OI-LS-374;
EMBASE-OI-5/14/2007
The Hepatitis C Virus Life Cycle as a Target for New Antiviral
Therapies
Pawlotsky, Jean-Michel, Chevaliez, Stephane, and McHutchison, John
G
Gastroenterology 2007.
132(5): 1979-1998
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WFX-4NN7Y57-S/2/3e87f421f22aaaade7493f318723a735
18.
60854 OI-LS-374;
EMBASE-OI-5/14/2007
A method for in vitro assembly of hepatitis C virus core protein and for
screening of inhibitors
Fromentin, Remi, Majeau, Nathalie, Gagne, Marie-Eve Laliberte, Boivin,
Annie, Duvignaud, Jean-Baptiste, and Leclerc, Denis
Analytical Biochemistry 2007. In Press, Corrected Proof:
375
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6W9V-4ND60M3-5/2/dff5cbfe4f10056fe348583faa40f9d2
19.
60855 OI-LS-374;
EMBASE-OI-5/14/2007
Phosphorylation of hepatitis C virus NS5A nonstructural protein: A new
paradigm for phosphorylation-dependent viral RNA replication?
Huang, Ying, Staschke, Kirk, De Francesco, Raffaele, and Tan,
Seng-Lai
Virology 2007. In
Press, Corrected Proof: 375
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4ND70B3-1/2/9bbac33ce873b9da3c04ff8a5a649577
20.
60856 OI-LS-374;
EMBASE-OI-5/14/2007
Synthesis, stereochemistry and antimicrobial evaluation of
t(3)-benzyl-r(2),c(6)-diarylpiperidin-4-one and its derivatives
Jayabharathi, J, Manimekalai, A, Consalata Vani, T, and Padmavathy,
M
European Journal of Medicinal Chemistry 2007. 42(5): 593-605
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VKY-4MFSNYJ-3/2/6a0854d9176c7b1c431b14c7255a3a9e
21.
60857 OI-LS-374;
EMBASE-OI-5/14/2007
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: Synthesis and
Biological Activity of a New Class of Highly Potent Inhibitors of Human
Cytomegalovirus DNA Polymerase
Larsen, Scott D, Zhang, Zhijun, DiPaolo, Brian A, Manninen, Peter R,
Rohrer, Douglas C, Hageman, Michael J, Hopkins, Todd A, Knechtel, Mary L, Oien,
Nancee L, Rush, Bob D, Schwende, Francis J, Stefanski, Kevin J, Wieber, Janet L,
Wilkinson, Karen F, Zamora, Kathyrn M, Wathen, Michael W, and Brideau, Roger
J
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Accepted Manuscript:
927
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4NP980V-5/2/0533de43ab76b946aeccd13baca0eb37
22.
60858 OI-LS-374;
WOS-OI-5/4/2007
Synthesis, critical micelle concentrations, and antimycobacterial
properties of homologous, dendritic amphiphiles. Probing intrinsic activity and
the "cutoff" effect
Sugandhi, EW, Macri, RV, Williams, AA, Kite, BL, Slebodnick, C,
Falkinham, JO, Esker, AR, and Gandour, RD
JOURNAL OF MEDICINAL CHEMISTRY 2007. 50(7): 1645-1650
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245259000023
23.
60859 OI-LS-374;
WOS-OI-5/4/2007
The manzamines as an example of the unique structural classes available
for the discovery and optimization of infectious disease controls based on
marine natural products
Hamann,
MT
CURRENT PHARMACEUTICAL DESIGN 2007. 13(6): 653-660
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245201200008
24.
60860 OI-LS-374;
WOS-OI-5/4/2007
P56 LCK inhibitor identification by pharmacophore modelling and molecular
docking
Bharatham, N, Bharatham, K, and Lee, KW
BULLETIN OF THE KOREAN CHEMICAL SOCIETY 2007. 28(2): 200-206
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245197800010
25.
60861 OI-LS-374;
WOS-OI-5/11/2007
Dimethyldithioimidocarbonates-mediated heterocyclizations: Synthesis of
imidazolidines and benzheterocycles as potent antitubercular
agents
Hegde, VS, Kolavi, GD, Lamani, RS, and Khazi, IAM
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS 2007. 182(4): 911-920
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245316700020
26.
60862 OI-LS-374;
WOS-OI-5/11/2007
Combinatorial RNAi: A winning strategy for the race against evolving
targets?
Grimm, D and Kay, MA
MOLECULAR THERAPY 2007.
15(5): 878-888
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000245999500006